Early <i>vs</i> conventional initiation of adjuvant chemotherapy in advanced gastric cancer: A propensity-matched outcomes study
Early AC initiation appears feasible in selected patients but necessitates individualized dose management. Our findings challenge traditional timing paradigms while highlighting the need for molecularly guided treatment sequencing strategies.
Authors
- Yifan Xiao (ORCID: https://orcid.org/0000-0001-5049-0288)
- Peng Zhang (ORCID: https://orcid.org/0000-0001-5345-3810)
- Zhikun Li (ORCID: https://orcid.org/0000-0003-2860-3965)
- Weiping Chen (ORCID: https://orcid.org/0000-0002-0459-0605)
- Guoyan Liu
- Lei Wen (ORCID: https://orcid.org/0000-0002-9363-092X)
- Yifan Cai (ORCID: https://orcid.org/0000-0002-3681-2890)
- Li Lin (ORCID: https://orcid.org/0009-0008-6832-2731)
- Ya-Yue Wang
Institutions
- Fujian Medical University (CN)
- Xiamen University (CN)
- First Affiliated Hospital of Xiamen University (CN)
- Zhongshan Hospital of Xiamen University (CN)
- Xiamen University of Technology (CN)
Publication Details
- Journal
- World Journal of Gastroenterology
- Published
- 2025-11-13
- DOI
- https://doi.org/10.3748/wjg.v31.i42.110069
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00